Effect of Physalis Peruviana Consumption on Blood Glucose in Overweight or Obese Young Adults
Introduction: Physalis peruviana, also known as aguaymanto, uchuva or golden berry, is a plant native to the Peruvian Andes which has been attributed the ability to reduce glycemia. Objectives: To evaluate the effect of Physalis peruviana consumption on glycemia in overweight or obese young adults....
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Universidad de Antioquia
2025-01-01
|
| Series: | Iatreia |
| Subjects: | |
| Online Access: | https://revistas.udea.edu.co/index.php/iatreia/article/view/353722 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: Physalis peruviana, also known as aguaymanto, uchuva or golden berry, is a plant native to the Peruvian Andes which has been attributed the ability to reduce glycemia.
Objectives: To evaluate the effect of Physalis peruviana consumption on glycemia in overweight or obese young adults.
Materials and Methods: Pre- and post-test quasi-experimental study with a sample of 28 young adults between 18-26 years old randomly divided into 2 groups: unmasked control and experimental. The average age was 21.6 years and the body mass index (BMI) 28.7. Fasting blood samples were taken before the study and weekly for 21 days; in parallel, 50 g of whole P. peruviana fruits were administered daily to the experimental group. Both groups adopted a standardized low-sugar diet and the evaluation of means was performed with Student's t-test.
Results: At baseline, no significant differences (p=0.563) were found in glycemic levels between the two groups. No differences in weight or BMI were found over the three weeks. At the end of the study, glycemia decreased, in both the experimental and control groups (12.5 and 16.1 mg/dL, respectively), with no significant difference (p=0.141).
Conclusions: The inclusion of whole fruit consumption of P. peruviana did not exert a greater hypoglycemic effect at the end of the three-week treatment period. |
|---|---|
| ISSN: | 0121-0793 2011-7965 |